3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gynecologic
1
Conditions
Colorectal Neoplasms
2
Uterine Prolapse
1
Uterine Cervical Neoplasms
1
Thyroid Cancer, Papillary
1
Thymoma
1
Surgery
1
Precancerous Conditions
1
Ovarian Neoplasms
1
Neoadjuvant Chemoimmunotherapy
1
Myasthenia Gravis
1
Menstruation Disturbances
1
Lymphatic Metastasis
1
Leiomyoma
1
Invasive Breast Carcinoma
1
Gastrointenstinal Stromal Tumor (GIST)
1
Esophageal Neoplasms
1
Endometriosis
1
Endometrial Neoplasms
1
Colonic Neoplasms
1
Adenomyosis
1
Interventions
relugolix
5
Uterine Myomectomy
5
Bupivacaine
4
epigallocatechin gallate
2
Vitamin D
2
Vitamin B 6
2
Sodium Chloride
2
Observation
2
Norethindrone Acetate
2
Estradiol
2
vilaprisan
1
linzagolix
1
elagolix
1
Videotape Recording
1
Uterine Artery Embolization
1
Triamcinolone Acetonide
1
Triamcinolone
1
Therapeutics
1
Tea
1
Surveys and Questionnaires
1
Standard of Care
1
Simvastatin
1
Saline Solution
1
Robotic Surgical Procedures
1
Restraint, Physical
1
Radiofrequency Ablation
1
Naproxen
1
Morphine
1
Methadone
1
Megestrol Acetate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Leiomyoma
×
Robotic Surgical Procedures
×
1 year
×
Clear all
NCT07120945
2026-06-02
Embrace Gyn
Medtronic - MITG
Phase NA
Active not recruiting
70 enrolled